Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma

BACKGROUND: Live attenuated influenza vaccine (LAIV) is recommended for annual influenza vaccination in children from age 2 years. However, some guidelines recommend against its use in children with asthma or recurrent wheeze due to concerns over its potential to induce wheezing. OBJECTIVE: We sough...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Paul J., Fleming, Louise, Saglani, Sejal, Southern, Jo, Andrews, Nick J., Miller, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mosby 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156909/
https://www.ncbi.nlm.nih.gov/pubmed/31863808
http://dx.doi.org/10.1016/j.jaci.2019.12.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156909/
https://www.ncbi.nlm.nih.gov/pubmed/31863808
http://dx.doi.org/10.1016/j.jaci.2019.12.010

Ejemplares similares